Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis

Oncogene

Volumn 19, Issue 29, 2000, Pages 3256-3265

  Timme, Terry L ^a   Goltsov, Alexei ^a   Tahir, Salahaldin ^a   Li, Likun ^a   Wang, Jianxiang ^a   Ren, Chengzhen ^a   Johnston, Randal N ^b   Thompson, Timothy C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Apoptosis; c myc; Caveolin; Prostate cancer

Indexed keywords

CAVEOLIN; VIRUS VECTOR;

ADENOVIRUS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; DOWN REGULATION; GENE ACTIVATION; GENE CONTROL; ONCOGENE C MYC; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ADENOVIRIDAE;

EID: 0034612591     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203654     Document Type: Article

References (50)

1. Adams JM and Cory S. (1998). Science, 281, 1322-1326.
2. Bist A, Fielding PE and Fielding CJ. (1997). Proc. Natl. Acad. Sci. USA, 94, 10693-10698.
3. Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch MJ, Sauter G and Kallioniemi OP. (1999). Cancer Res., 59, 803-806.
4. Claassen GF and Hann SR. (1999). Oncogene, 18, 2925-2933.
5. Dang CV. (1999). Mol. Cell. Biol., 19, 1-11.
6. Eilers M, Picard D, Yamamoto KR and Bishop JM. (1989). Nature. 340, 66-68.
7. Eilers M, Schirm S and Bishop JM. (1991). EMBO J., 10, 133-141.
8. Engelman JA, Wykoff CC, Yasuhara S, Song KS, Okamoto T and Lisanti MP. (1997). J. Biol. Chem., 272, 16374-16381.
9. Evan GI, Wyllie Ah, Gilbert GS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC. (1992). Cell, 69, 119-128.
10. Evan G and Littlewood T. (1998). Science, 281, 1317-1322.
11. Facchini LM and Penn LZ. (1998). FASEB J., 12, 633-651.
12. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG and Lisanti MP. (1998). EMBO J., 17, 6633-6648.
13. Grandori C and Eisenman RN. (1997). Trends Biochem. Sci., 22, 177-181.
14. Harrington EA, Bennett MR, Fanidi A and Evan GI. (1994). EMBO J., 13, 3286-3295.
15. Helbing CC, Wellington CL, Gogela-Spehar M, Cheng T, Pinchbeck GG and Johnston RN. (1998). Oncogene, 17, 1491-1501.
16. Hermeking H and Eick D. (1994). Science. 265, 2091-2093.
17. Hurlstone AF, Reid G, Reeves JR, Fraser J, Strathdee G, Rahilly M, Parkinson EK and Black DM. (1999). Oncogene, 18, 1881-1890.
18. Jenkins RB, Qian J, Lieber MM and Bostwick DG. (1997). Cancer Res., 57, 524-531.
19. Kangas A, Nicholson DW and Hottla E. (1998). Oncogene, 16, 387-398.
20. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J and Evan G. (1997). Nature, 385, 544-548.
21. Koleske AJ, Baltimore D and Lisanti MP. (1995). Proc. Natl. Acad. Sci. USA, 92, 1381-1385.
22. Lavie Y, Fiucci G and Liscovitch M. (1998). J. Biol Chem., 273, 32380-32383.
23. Lee SW, Reimer CL, Oh P, Campbell DB and Schnitzer JE. (1998). Oncogene, 16, 1391-1397.
24. Li LH, Nerlov C, Prendergast G, MacGregor D, and Ziff EB. (1994). EMBO J., 13, 4070-4079.
25. Littlewood TD, Hancock DC, Danielian PS, Parker MG and Evan GI. (1995). Nucleic Acids Res., 23, 1686-1690.
26. Marcu KB, Bossone SA and Patel AJ. (1992). Annu. Rev. Biochem., 61, 809-860.
27. Marhin WW, Chen S, Facchini LM, Fornace Jr AJ and Penn LZ. (1997). Oncogene, 14, 2825-2834.
28. McCarthy NJ, Whyte MK, Gilbert CS and Evan GI. (1997). J. Cell Biol., 136, 215-227.
29. Nasu Y, Timme TL, Yang G, Bangma CH, Li L, Ren C, Park SH, DeLeon M, Wang J and Thompson TC. (1998). Nat. Med., 4, 1062-1064.
30. Nupponen NN, Kakkola L, Koivisto P and Visakorpi T. (1998). Am. J. Pathol., 153, 141-148.
31. Parton RG. (1996). Curr. Opin. Cell. Biol., 8, 542-548.
32. Prendergast GC. (1999). Oncogene, 18, 2967-2987.
33. Qian J, Jenkins RB and Bostwick DG. (1997). Mod. Pathol., 10, 1113-1119.
34. Roy AL, Carruthers C, Gutjahr T and Roeder RG. (1993). Nature, 365, 359-361.
35. Sato K, Qian J, Slezak JM, Lieber MM, Bostwick DG, Bergstralh EJ and Jenkins RB. (1999). J. Natl. Cancer Inst., 91, 1574-1580.
36. Sears R, Leone G, DeGregori J and Nevins JR. (1999). Mol. Cell, 3, 169-179.
37. Shaul PW and Anderson RG. (1998). Am. J. Physiol., 275, L843-851.
38. Shinoura N, Yoshida Y, Nishimura M, Muramatsu Y, Asai A, Kirino T and Hamada H. (1999). Cancer Res., 59, 4119-4128.
39. Srivastava RK, Sollott SJ, Khan L, Hansford R, Lakatta EG and Longo DL. (1999). Mol. Cell Biol., 19, 5659-5674.
40. Thompson TC, Southgate J, Kitchener G and Land H. (1989). Cell, 56, 917-930.
41. Thompson TC, Timme T, Li L, Goltsov A and Yang G. (1999a). Emerging Therapeutic Targets, 3, 337-346.
42. Thompson TC, Timme TL, Li L and Goltsov A. (1999b). Apoptosis, 4, 233-237.
43. Ulrich E, Duwel A, Kauffmann-Zeh A, Gilbert C, Lyon D, Rudkin B, Evan G and Martin-Zanca D. (1998). Oncogene, 16, 825-832.
44. Vairo G, Innes KM and Adams JM. (1996). Oncogene, 13, 1511-1519.
45. Wagner AJ, Kokontis JM and Hay N. (1994). Genes Dev., 8, 2817-2830.
46. Wu KJ, Polack A and Dalla-Favera R. (1999). Science, 283, 676-679.
47. Yang CP, Galbiati F, Volonte D, Horwitz SB and Lisanti MP. (1998a). FEBS Lett., 439, 368-372.
48. Yang G, Truong LD, Timme TL, Ren C, Wheeler TM, Park SH, Nasu Y, Bangma CH, Kattan MW, Scardino PT and Thompson TC. (1998b). Clin. Cancer Res., 4, 1873-1880.
49. Yang G, Truong LD, Wheeler TM and Thompson TC. (1999). Cancer Res., 59, 5719-5723.
50. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF. (1998). Genes Dev., 12, 2424-2433.